Synopsis of recent research by authors named "Mark Hellmann"
- Mark Hellmann's recent research focuses primarily on optic neuritis (ON) and its relationship with demyelinating diseases such as multiple sclerosis (MS) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), including diagnostic criteria and treatment protocols for these conditions
- His studies have evaluated the effects of COVID-19 vaccinations on MS activity and explored the treatment effectiveness of intravenous immunoglobulins (IVIG) for acute MOGAD attacks, as well as the impact of corticosteroid treatment protocols on visual outcomes in ON
- Additionally, research by Hellmann has addressed underlying factors linked to ON and MOGAD, such as the role of body weight in disease prevalence, and the use of retrospective cohorts to better understand the outcomes and diagnostic measures in patients experiencing acute demyelinating events
